Market Overview

USANA Health Sciences' China Subsidiary BabyCare Ltd. Receives Approval for Three Additional Direct Selling Licenses in Mainland China

Related USNA
5 NYSE Healthcare Stocks With The Highest ROI
USANA Health Sciences Is Worth $165/Share And It's A Buy, D.A. Davidson Says
Herbalife Stock Gets Healthy Bounce On Court Ruling (Investor's Business Daily)

USANA Health Sciences Inc. (NYSE: USNA), a global nutritional company, announced today that its China subsidiary BabyCare Ltd. received official government approval from the Ministry of Commerce People's Republic of China (MOFCOM) to expand direct selling activities in three additional provinces/municipalities within the People's Republic of China. The provinces/municipalities include Jiangsu, Shanxi and Tianjin.

Posted-In: News Legal Global


Related Articles (USNA)

Get Benzinga's Newsletters